Table 2.
Need for conventional mechanical ventilation (CMV) and incidence of BPD in preterm infants with RDS treated with INSURE approach using surfactant administration through a thin plastic catheter [MIST or LIST – minimally (or less) invasive surfactant therapy and LISA (less invasive surfactant administration)] vs. endotracheal tube (ETT).
| Study | N (gestation) | Need for CMV Catheter vs. ETT | Incidence of BPD Catheter vs. ETT | Entry criteria for catheter |
|---|---|---|---|---|
| Gopel 80 | 2206 (26–28 weeks) | 41% vs. 62% (P < 0.001) | 12% vs. 18% (P = 0.001) | Cohort study not specified |
| Kanmaz81 | 200 (< 32 weeks) | 40% vs. 49% (P = NS) | 10.3% vs. 20.2% Moderate-Severe P = 0.009 |
FiO2 > 0.4 & CPAP |
| Gopel82 | 220 (26–28 weeks) | 33% vs. 73% (P < 0.0001) | 8% vs. 13% P = 0.268 |
FiO2 > 0.3 & CPAP |
| Kribs83 | 211 (23–26.8 weeks) | 74.8% vs. 99% (P < 0.001) | 67.3% vs. 58.7% Survival without BPD (P = NS) |
FiO2 > 0.3 & CPAP in first 2 hours |
| Mohammadizadeh84 | 38 (<34 weeks) | 15.8% vs. 10.5% (P=NS) | (P = NS) | CPAP & need for surfactant |
| Bao85 | 90 (27–32 weeks | 17.0% vs. 23.3% (P = NS) | (P = NS) | FiO2 = 0.30–0.35 & CPAP |
| Mirnia86 | 136 (27–32 weeks) | 19% vs. 22% (P =NS) | 7.5% vs. 7.1% (P = NS) | FiO2 > 0.3 & CPAP |
Abbreviations: N, number; CMV, conventional mechanical ventilation; ETT, endotracheal tube; BPD, bronchopulmonary dysplasisa; CPAP, continuous positive airway pressure; NS, non-significant